Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials.

AIM:To assess the effect of Lactobacillus supplementation on Helicobacter pylori eradication rates and side effects of the triple therapy. METHODS:PubMed, Embase, Web of Science and Cochrane Library were searched for articles published up to July, 2019. Review Manager 5.3 and Stata 12.0 were used fo...

Full description

Bibliographic Details
Main Authors: Mingyang Yu, Rongguang Zhang, Peng Ni, Shuaiyin Chen, Guangcai Duan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0223309
id doaj-003d2141a2d640af900f6d2154507653
record_format Article
spelling doaj-003d2141a2d640af900f6d21545076532021-03-03T21:12:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-011410e022330910.1371/journal.pone.0223309Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials.Mingyang YuRongguang ZhangPeng NiShuaiyin ChenGuangcai DuanAIM:To assess the effect of Lactobacillus supplementation on Helicobacter pylori eradication rates and side effects of the triple therapy. METHODS:PubMed, Embase, Web of Science and Cochrane Library were searched for articles published up to July, 2019. Review Manager 5.3 and Stata 12.0 were used for statistical analyses. RESULTS:The initial database search resulted in 852 articles. Through exclusion and screening, 11 randomized controlled trials involving a total of 724 patients were finally included in this meta-analysis. The H. pylori elimination rate in the Lactobacillus supplement group was significantly higher than that in the control group (RR 1.16, 95% CI 1.08-1.25, P<0.0001). Subgroup analysis showed that the eradication rates were significantly enhanced in both adults and children group, and no significant difference was detected between Asia and Europe group. In addition, sub-analysis based on duration of Lactobacillus supplementation showed the pooled RRs in the long-term and short-term groups were 1.17 (95%CI 1.06-1.30) and 1.16 (95% CI 1.04-1.30), respectively. Regarding the Lactobacillus strains, the pooled RR was 1.33 (95% CI 1.10-1.62) in the L. casei group, 1.18 (95% CI 1.03-1.34) in the L. reuteri group while 1.02 (95% CI 0.87-1.21) in the Lactobacillus GG group. As for the total side effects, Lactobacillus supplementation significantly reduced the incidence of taste disturbance (RR = 0.36, 95% CI 0.17-0.74, P = 0.005). CONCLUSIONS:Lactobacillus supplementation during the treatment of Helicobacter pylori infection can effectively improve the eradication rates, and reduce the incidence of therapy-related taste disturbance.https://doi.org/10.1371/journal.pone.0223309
collection DOAJ
language English
format Article
sources DOAJ
author Mingyang Yu
Rongguang Zhang
Peng Ni
Shuaiyin Chen
Guangcai Duan
spellingShingle Mingyang Yu
Rongguang Zhang
Peng Ni
Shuaiyin Chen
Guangcai Duan
Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials.
PLoS ONE
author_facet Mingyang Yu
Rongguang Zhang
Peng Ni
Shuaiyin Chen
Guangcai Duan
author_sort Mingyang Yu
title Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials.
title_short Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials.
title_full Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials.
title_fullStr Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials.
title_full_unstemmed Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials.
title_sort efficacy of lactobacillus-supplemented triple therapy for h. pylori eradication: a meta-analysis of randomized controlled trials.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2019-01-01
description AIM:To assess the effect of Lactobacillus supplementation on Helicobacter pylori eradication rates and side effects of the triple therapy. METHODS:PubMed, Embase, Web of Science and Cochrane Library were searched for articles published up to July, 2019. Review Manager 5.3 and Stata 12.0 were used for statistical analyses. RESULTS:The initial database search resulted in 852 articles. Through exclusion and screening, 11 randomized controlled trials involving a total of 724 patients were finally included in this meta-analysis. The H. pylori elimination rate in the Lactobacillus supplement group was significantly higher than that in the control group (RR 1.16, 95% CI 1.08-1.25, P<0.0001). Subgroup analysis showed that the eradication rates were significantly enhanced in both adults and children group, and no significant difference was detected between Asia and Europe group. In addition, sub-analysis based on duration of Lactobacillus supplementation showed the pooled RRs in the long-term and short-term groups were 1.17 (95%CI 1.06-1.30) and 1.16 (95% CI 1.04-1.30), respectively. Regarding the Lactobacillus strains, the pooled RR was 1.33 (95% CI 1.10-1.62) in the L. casei group, 1.18 (95% CI 1.03-1.34) in the L. reuteri group while 1.02 (95% CI 0.87-1.21) in the Lactobacillus GG group. As for the total side effects, Lactobacillus supplementation significantly reduced the incidence of taste disturbance (RR = 0.36, 95% CI 0.17-0.74, P = 0.005). CONCLUSIONS:Lactobacillus supplementation during the treatment of Helicobacter pylori infection can effectively improve the eradication rates, and reduce the incidence of therapy-related taste disturbance.
url https://doi.org/10.1371/journal.pone.0223309
work_keys_str_mv AT mingyangyu efficacyoflactobacillussupplementedtripletherapyforhpylorieradicationametaanalysisofrandomizedcontrolledtrials
AT rongguangzhang efficacyoflactobacillussupplementedtripletherapyforhpylorieradicationametaanalysisofrandomizedcontrolledtrials
AT pengni efficacyoflactobacillussupplementedtripletherapyforhpylorieradicationametaanalysisofrandomizedcontrolledtrials
AT shuaiyinchen efficacyoflactobacillussupplementedtripletherapyforhpylorieradicationametaanalysisofrandomizedcontrolledtrials
AT guangcaiduan efficacyoflactobacillussupplementedtripletherapyforhpylorieradicationametaanalysisofrandomizedcontrolledtrials
_version_ 1714818140970418176